Global Plantar Fasciitis Treatment Market Set for Rapid Growth, to reach Value around USD 2,469.1 Million by 2025

Zion Market Research has published a new report titled “Plantar Fasciitis Treatment Market by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025”. According to the report, global demand for plantar fasciitis treatment market was valued at approximately USD 603.3 million in 2018, and is expected to generate revenue of around USD 2,469.1 million by end of 2025, growing at a CAGR of around 22.3% between 2019 and 2025.

Browse the full “Plantar Fasciitis Treatment Market: by Type (Medication Therapy [Oral, and Parenteral], Orthotics, Shockwave Therapy [Extracorporeal Shock Wave Therapy, and Intracorporeal Pneumatic Shockwave Therapy], Surgery, and Others), and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025” Report at https://www.zionmarketresearch.com/report/plantar-fasciitis-treatment-market

Plantar fasciitis is highly prevalent among the population who stand on hard or rough surfaces for longer periods of time and is a type of inflammation of muscle of the soles. It is the most common causes of injuries which are related to the feet. It usually affects the heel portion of the foot resulting into tenderness of the sole. This disease affects runners, hikers, and walkers, and those who stand for their living and has emerged as a persistent repetitive strain injury.

Extensive range of treatments which are combating severe pain and inflammation caused due to plantar fasciitis, has widened the scope of market growth for leading stakeholders of this market. Large portion of the working class stands for longer sustained time during their jobs and suffer from severe body pain, precisely ankle and foot pain which is among the prominent causes of plantar fasciitis and has also attributed to the fact that, that manufacturing sector is continuously expanding at unprecedented rate of the global population which is engaged in this industry, who stands for a longer durations thus boosting the market growth globally.

The market for plantar fasciitis treatment is segmented based on end user, type, and regions. Based on type the market for plantar fasciitis treatment is segmented into medication therapy, orthotics, shockwave therapy, surgery, and others. The market for shockwave therapy is further sub-segmented into intracorporeal pneumatic shockwave therapy, and extracorporeal shock wave therapy. The medication therapy market is further segmented into parenteral, and oral. The segment for shockwave therapy is likely to show high growth rate in the forecast period as plantar fasciitis is gaining momentum since it is the most common foot pain conditions which have raised number of treatments globally. Based on end user the market is segmented into clinics, ambulatory surgical centers, hospitals, and others. The segment for hospitals held major share of the market in 2018 as this medication therapy is most widely adopted line of therapy in hospitals to manage symptoms related to plantar fasciitis like pain and inflammation. 

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries. North America held major share of the market in 2018. The prevalence and diagnosis rate of plantar fasciitis is growing rapidly in North America. Besides, changing lifestyle and rise in obese population base in the U.S. is also further boosting the plantar fasciitis treatment market in North America.

Some of the players in the market for plantar fasciitis treatment include Pfizer, Inc., A. Algeo Limited, Inc., Ottobock SE & Co., KGaA (Ottobock Holding), Hanger, Inc., Bayer Group (Dr. Scholl's), Bauerfeind AG, GlaxoSmithKline Plc, Superfeet Worldwide, and Sanofi.

This report segments the global plantar fasciitis treatment market as follows:

Global Plantar Fasciitis Treatment Market: Type Segment Analysis

• Medication Therapy
  • Oral
  • Parenteral
• Orthotics
• Shockwave Therapy
  • Extracorporeal Shock Wave Therapy (ESWT)
  • Intracorporeal Pneumatic Shockwave Therapy (IPST)
• Surgery
• Others

Global Plantar Fasciitis Treatment Market: End User Segment Analysis

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Global Plantar Fasciitis Treatment Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com